Peng Cui
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Cancer Genomics and Diagnostics 2
-
- Circular RNAs in diseases 2
- RNA modifications and cancer 2
- RNA Research and Splicing 2
- Co-authors
- Shaojie Li (1 shared paper)Baohua Hou (1 shared paper)Zhixiang Jian (1 shared paper)Jie Wang (1 shared paper)Shangli Cai (2 shared papers)Jia Fan (1 shared paper)Chengcheng Li (1 shared paper)Zhijie Wang (1 shared paper)
- Journals
- OncoTargets and Therapy (2 papers)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (1 paper)Combinatorial Chemistry & High Throughput Screening (1 paper)BioMed Research International (1 paper)Molecular Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Peng Cui
12 papers receiving 269 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 155
- Molecular Biology 153
- Oncology 36
- Pulmonary and Respiratory Medicine 24
- Biochemistry 5
Countries citing papers authored by Peng Cui
This map shows the geographic impact of Peng Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Cui more than expected).
Fields of papers citing papers by Peng Cui
This network shows the impact of papers produced by Peng Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Cui. The network helps show where Peng Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Peng Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 98 | |
| 2 | 2015 | 57 | |
| 3 | 2019 | 22 | |
| 4 | 2019 | 20 | |
| 5 | 2017 | 16 | |
| 6 | 2017 | 14 | |
| 7 | 2022 | 12 | |
| 8 | 2013 | 10 | |
| 9 | 2017 | 9 | |
| 10 | 2024 | 8 | |
| 11 | 2015 | 6 | |
| 12 | 2025 | 1 | |
| 13 | 2023 | 0 |
About Peng Cui
Peng Cui is a scholar working on Cancer Research, Molecular Biology, Oncology, Epidemiology and Surgery, having authored 13 papers that have together received 273 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer Genomics and Diagnostics (2 papers), Circular RNAs in diseases (2 papers), RNA modifications and cancer (2 papers), RNA Research and Splicing (2 papers) and Circadian rhythm and melatonin (1 paper). The work is most often cited by research in Cancer Research (155 citations), Molecular Biology (153 citations), Oncology (36 citations), Pulmonary and Respiratory Medicine (24 citations) and Biochemistry (5 citations). Peng Cui has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Shaojie Li, Baohua Hou, Zhixiang Jian, Jie Wang, Shangli Cai, Jia Fan, Chengcheng Li, Zhijie Wang, Zhu Xin and Guoqiang Wang. Their work appears in journals such as OncoTargets and Therapy, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Combinatorial Chemistry & High Throughput Screening, BioMed Research International and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.